Exploring regenerative medicine strategies for osteoporosis treatment: Progress, potential, and hurdles
Department of microbiology, St. Xavier’s College, Kolkata, India.
Review
World Journal of Biology Pharmacy and Health Sciences, 2024, 17(02), 344–349
Article DOI: 10.30574/wjbphs.2024.17.2.0078
Publication history:
Received on 06 January 2024; revised on 16 February 2024; accepted on 19 February 2024
Abstract:
A major worldwide health problem is osteoporosis, particularly in older people. There are restrictions on current therapies, such as anti-resorptive medications. Promising techniques including stem cell treatment, gene therapy, and growth factors are available in regenerative medicine. Preclinical and clinical research indicate promise for mesenchymal stem cells derived from bone marrow, adipose tissue, and umbilical cord blood. Enhancing bone regeneration with gene therapy that targets osteogenic factors such as BMPs is a promising approach. In order to mend bones, growth factors, cytokines, and scaffold materials are essential. Realising the benefits of regenerative medicine in treating osteoporosis requires cooperation and ongoing research, despite obstacles such limited clinical acceptability and regulatory barriers.
Keywords:
Osteoporosis; Regenerative Medicine; Stem Cells; Gene Therapy; Growth Factors.
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0